1	Monocytes	_	NNS	_	_	2	VMOD	_	_
2	are	_	VBP	_	_	0	ROOT	_	_
3	produced	_	VBN	_	_	2	VC	_	_
4	in	_	IN	_	_	3	VMOD	_	_
5	the	_	DT	_	_	7	NMOD	_	_
6	bone	_	NN	_	_	7	NMOD	_	_
7	marrow	_	NN	_	_	4	PMOD	_	_
8	and	_	CC	_	_	2	COORD	_	_
9	circulate	_	VBP	_	_	8	CONJ	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	blood	_	NN	_	_	10	PMOD	_	_
12	for	_	IN	_	_	9	VMOD	_	_
13	24-48	_	CD	_	_	14	NMOD	_	_
14	hours	_	NNS	_	_	12	PMOD	_	_
15	[	_	(	_	_	16	P	_	_
16	1	_	CD	_	_	9	PRN	_	_
17	]	_	)	_	_	16	P	_	_
18	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	the	_	DT	_	_	1	DEP	_	_
3	absence	_	NN	_	_	1	DEP	_	_
4	of	_	IN	_	_	1	DEP	_	_
5	serum	_	NN	_	_	1	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	monocytes	_	NNS	_	_	8	VMOD	_	_
8	die	_	VBP	_	_	0	ROOT	_	_
9	via	_	IN	_	_	8	VMOD	_	_
10	apoptosis	_	NN	_	_	9	PMOD	_	_
11	[	_	(	_	_	12	P	_	_
12	1	_	LS	_	_	8	VMOD	_	_
13	]	_	)	_	_	12	P	_	_
14	,	_	,	_	_	12	P	_	_
15	[	_	(	_	_	16	P	_	_
16	2	_	LS	_	_	12	COORD	_	_
17	]	_	)	_	_	16	P	_	_
18	.	_	.	_	_	8	P	_	_
		
1	Macrophage	_	NN	_	_	3	NMOD	_	_
2	colony-stimulating	_	JJ	_	_	3	NMOD	_	_
3	factor	_	NN	_	_	7	VMOD	_	_
4	(	_	(	_	_	5	P	_	_
5	M-CSF	_	NN	_	_	3	PRN	_	_
6	)	_	)	_	_	5	P	_	_
7	stimulates	_	VBZ	_	_	0	ROOT	_	_
8	mononuclear	_	JJ	_	_	10	NMOD	_	_
9	phagocyte	_	NN	_	_	10	NMOD	_	_
10	survival	_	NN	_	_	7	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	differentiation	_	NN	_	_	11	CONJ	_	_
13	[	_	(	_	_	12	P	_	_
14	3	_	CD	_	_	12	NMOD	_	_
15	]	_	)	_	_	12	P	_	_
16	.	_	.	_	_	7	P	_	_
		
1	Importantly	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	M-CSF-mediated	_	JJ	_	_	5	NMOD	_	_
4	cell	_	NN	_	_	5	NMOD	_	_
5	survival	_	NN	_	_	8	VMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	activation	_	NN	_	_	6	CONJ	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	associated	_	VBN	_	_	8	VC	_	_
10	with	_	IN	_	_	9	VMOD	_	_
11	a	_	DT	_	_	12	NMOD	_	_
12	variety	_	NN	_	_	10	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	human	_	JJ	_	_	15	NMOD	_	_
15	diseases	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	including	_	VBG	_	_	15	NMOD	_	_
18	atherosclerosis	_	NN	_	_	17	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	transplant	_	NN	_	_	22	NMOD	_	_
21	vascular	_	JJ	_	_	22	NMOD	_	_
22	sclerosis	_	NN	_	_	18	APPO	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	breast	_	NN	_	_	26	NMOD	_	_
25	cancer	_	NN	_	_	26	NMOD	_	_
26	metastasis	_	NN	_	_	23	CONJ	_	_
27	[	_	(	_	_	26	P	_	_
28	4	_	CD	_	_	26	NMOD	_	_
29	]	_	)	_	_	26	P	_	_
30	,	_	,	_	_	18	P	_	_
31	[	_	(	_	_	32	P	_	_
32	5	_	CD	_	_	18	PRN	_	_
33	]	_	)	_	_	32	P	_	_
34	,	_	,	_	_	15	P	_	_
35	[	_	(	_	_	36	P	_	_
36	6	_	CD	_	_	9	PRN	_	_
37	]	_	)	_	_	36	P	_	_
38	.	_	.	_	_	8	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	previously	_	RB	_	_	3	VMOD	_	_
3	identified	_	VBD	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	NF-kappaB	_	NN	_	_	6	NMOD	_	_
6	activation	_	NN	_	_	7	VMOD	_	_
7	is	_	VBZ	_	_	4	SUB	_	_
8	important	_	JJ	_	_	7	VMOD	_	_
9	in	_	IN	_	_	8	AMOD	_	_
10	M-CSF-induced	_	JJ	_	_	12	NMOD	_	_
11	monocyte	_	NN	_	_	12	NMOD	_	_
12	survival	_	NN	_	_	9	PMOD	_	_
13	[	_	(	_	_	14	P	_	_
14	7	_	CD	_	_	12	PRN	_	_
15	]	_	)	_	_	14	P	_	_
16	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	15	VMOD	_	_
2	addition	_	NN	_	_	1	DEP	_	_
3	to	_	TO	_	_	1	DEP	_	_
4	its	_	PRP$	_	_	5	NMOD	_	_
5	role	_	NN	_	_	1	PMOD	_	_
6	in	_	IN	_	_	5	NMOD	_	_
7	mononuclear	_	JJ	_	_	9	NMOD	_	_
8	phagocyte	_	NN	_	_	9	NMOD	_	_
9	survival	_	NN	_	_	6	PMOD	_	_
10	,	_	,	_	_	15	P	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	transcription	_	NN	_	_	14	NMOD	_	_
13	factor	_	NN	_	_	14	NMOD	_	_
14	NF-kappaB	_	NN	_	_	15	VMOD	_	_
15	regulates	_	VBZ	_	_	0	ROOT	_	_
16	numerous	_	JJ	_	_	17	NMOD	_	_
17	genes	_	NNS	_	_	15	VMOD	_	_
18	that	_	WDT	_	_	19	VMOD	_	_
19	play	_	VBP	_	_	17	NMOD	_	_
20	important	_	JJ	_	_	21	NMOD	_	_
21	roles	_	NNS	_	_	19	VMOD	_	_
22	in	_	IN	_	_	19	VMOD	_	_
23	cellular	_	JJ	_	_	24	NMOD	_	_
24	signaling	_	NN	_	_	22	PMOD	_	_
25	,	_	,	_	_	24	P	_	_
26	stress	_	NN	_	_	27	NMOD	_	_
27	response	_	NN	_	_	24	COORD	_	_
28	,	_	,	_	_	27	P	_	_
29	cell	_	NN	_	_	30	NMOD	_	_
30	growth	_	NN	_	_	27	COORD	_	_
31	,	_	,	_	_	30	P	_	_
32	survival	_	NN	_	_	30	COORD	_	_
33	,	_	,	_	_	32	P	_	_
34	differentiation	_	NN	_	_	32	COORD	_	_
35	and	_	CC	_	_	34	COORD	_	_
36	inflammation	_	NN	_	_	35	CONJ	_	_
37	[	_	(	_	_	36	P	_	_
38	8	_	CD	_	_	36	NMOD	_	_
39	]	_	)	_	_	36	P	_	_
40	.	_	.	_	_	15	P	_	_
		
1	There	_	EX	_	_	2	VMOD	_	_
2	are	_	VBP	_	_	0	ROOT	_	_
3	five	_	CD	_	_	4	NMOD	_	_
4	members	_	NNS	_	_	2	VMOD	_	_
5	in	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	NF-kappaB	_	NN	_	_	8	NMOD	_	_
8	family	_	NN	_	_	5	PMOD	_	_
9	:	_	:	_	_	4	P	_	_
10	RelA/p65	_	NN	_	_	4	COORD	_	_
11	,	_	,	_	_	10	P	_	_
12	p50	_	NN	_	_	10	COORD	_	_
13	,	_	,	_	_	12	P	_	_
14	p52	_	NN	_	_	12	COORD	_	_
15	,	_	,	_	_	14	P	_	_
16	c-Rel	_	NN	_	_	14	COORD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	RelB	_	NN	_	_	17	CONJ	_	_
19	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	most	_	RBS	_	_	3	AMOD	_	_
3	common	_	JJ	_	_	5	NMOD	_	_
4	activating	_	NN	_	_	5	NMOD	_	_
5	complex	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	0	ROOT	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	p50/p65	_	NN	_	_	9	NMOD	_	_
9	heterodimer	_	NN	_	_	6	VMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	driven	_	VBN	_	_	9	APPO	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	activation	_	NN	_	_	15	NMOD	_	_
15	domain	_	NN	_	_	12	PMOD	_	_
16	in	_	IN	_	_	15	NMOD	_	_
17	the	_	DT	_	_	20	NMOD	_	_
18	NF-kappaB	_	NN	_	_	20	NMOD	_	_
19	p65	_	NN	_	_	20	NMOD	_	_
20	subunit	_	NN	_	_	16	PMOD	_	_
21	.	_	.	_	_	6	P	_	_
		
1	NF-kappaB	_	NN	_	_	2	NMOD	_	_
2	p65	_	NN	_	_	3	VMOD	_	_
3	regulates	_	VBZ	_	_	0	ROOT	_	_
4	important	_	JJ	_	_	6	NMOD	_	_
5	developmental	_	JJ	_	_	6	NMOD	_	_
6	processes	_	NNS	_	_	3	VMOD	_	_
7	[	_	(	_	_	8	P	_	_
8	9	_	CD	_	_	6	PRN	_	_
9	]	_	)	_	_	8	P	_	_
10	,	_	,	_	_	6	P	_	_
11	[	_	(	_	_	12	P	_	_
12	10	_	CD	_	_	6	APPO	_	_
13	]	_	)	_	_	12	P	_	_
14	.	_	.	_	_	3	P	_	_
		
1	Mice	_	NNS	_	_	5	VMOD	_	_
2	lacking	_	VBG	_	_	1	APPO	_	_
3	NF-kappaB	_	NN	_	_	4	NMOD	_	_
4	p65	_	NN	_	_	2	VMOD	_	_
5	die	_	VBP	_	_	0	ROOT	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	utero	_	NN	_	_	6	PMOD	_	_
8	and	_	CC	_	_	5	COORD	_	_
9	have	_	VBP	_	_	8	CONJ	_	_
10	extensive	_	JJ	_	_	12	NMOD	_	_
11	liver	_	NN	_	_	12	NMOD	_	_
12	damage	_	NN	_	_	9	VMOD	_	_
13	via	_	IN	_	_	9	VMOD	_	_
14	enhanced	_	VBN	_	_	15	NMOD	_	_
15	apoptosis	_	NN	_	_	13	PMOD	_	_
16	[	_	(	_	_	15	P	_	_
17	9	_	CD	_	_	15	NMOD	_	_
18	]	_	)	_	_	15	P	_	_
19	.	_	.	_	_	5	P	_	_
		
1	Embryonic	_	JJ	_	_	2	NMOD	_	_
2	macrophages	_	NNS	_	_	8	VMOD	_	_
3	from	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	NMOD	_	_
5	p65	_	NN	_	_	7	NMOD	_	_
6	null	_	JJ	_	_	7	NMOD	_	_
7	mice	_	NNS	_	_	3	PMOD	_	_
8	are	_	VBP	_	_	0	ROOT	_	_
9	susceptible	_	JJ	_	_	8	VMOD	_	_
10	to	_	TO	_	_	9	AMOD	_	_
11	TNFalpha-induced	_	JJ	_	_	12	NMOD	_	_
12	apoptosis	_	NN	_	_	10	PMOD	_	_
13	which	_	WDT	_	_	14	VMOD	_	_
14	is	_	VBZ	_	_	12	NMOD	_	_
15	rescued	_	VBN	_	_	14	VC	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	overexpressing	_	VBG	_	_	16	PMOD	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	NF-kappaB	_	NN	_	_	21	NMOD	_	_
20	p65	_	NN	_	_	21	NMOD	_	_
21	subunit	_	NN	_	_	17	VMOD	_	_
22	[	_	(	_	_	23	P	_	_
23	10	_	CD	_	_	21	PRN	_	_
24	]	_	)	_	_	23	P	_	_
25	.	_	.	_	_	8	P	_	_
		
1	Moreover	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	inhibiting	_	NN	_	_	4	NMOD	_	_
4	NF-kappaB	_	NN	_	_	5	VMOD	_	_
5	induces	_	VBZ	_	_	0	ROOT	_	_
6	cell	_	NN	_	_	7	NMOD	_	_
7	death	_	NN	_	_	5	VMOD	_	_
8	in	_	IN	_	_	5	VMOD	_	_
9	many	_	JJ	_	_	11	NMOD	_	_
10	cell	_	NN	_	_	11	NMOD	_	_
11	types	_	NNS	_	_	8	PMOD	_	_
12	and	_	CC	_	_	5	COORD	_	_
13	cytokine-independent	_	JJ	_	_	14	NMOD	_	_
14	survival	_	NN	_	_	15	VMOD	_	_
15	is	_	VBZ	_	_	12	CONJ	_	_
16	mediated	_	VBN	_	_	15	VC	_	_
17	by	_	IN	_	_	16	VMOD	_	_
18	constitutively	_	RB	_	_	19	AMOD	_	_
19	active	_	JJ	_	_	20	NMOD	_	_
20	NF-kappaB	_	NN	_	_	17	PMOD	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	murine	_	JJ	_	_	23	NMOD	_	_
23	macrophages	_	NNS	_	_	21	PMOD	_	_
24	[	_	(	_	_	25	P	_	_
25	11	_	CD	_	_	16	PRN	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	5	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	monocytes	_	NNS	_	_	1	PMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	macrophages	_	NNS	_	_	3	CONJ	_	_
5	,	_	,	_	_	7	P	_	_
6	NF-kappaB	_	NN	_	_	7	VMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	an	_	DT	_	_	11	NMOD	_	_
9	important	_	JJ	_	_	11	NMOD	_	_
10	transcriptional	_	JJ	_	_	11	NMOD	_	_
11	factor	_	NN	_	_	7	VMOD	_	_
12	for	_	IN	_	_	11	NMOD	_	_
13	expression	_	NN	_	_	12	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	cytokines	_	NNS	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	cell	_	NN	_	_	19	NMOD	_	_
18	surface	_	NN	_	_	19	NMOD	_	_
19	receptors	_	NNS	_	_	16	CONJ	_	_
20	[	_	(	_	_	21	P	_	_
21	12	_	CD	_	_	7	PRN	_	_
22	]	_	)	_	_	21	P	_	_
23	.	_	.	_	_	7	P	_	_
		
1	However	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	unlike	_	IN	_	_	8	VMOD	_	_
4	resting	_	VBG	_	_	5	NMOD	_	_
5	T-cells	_	NNS	_	_	3	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	NF-kappaB	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	constitutively	_	RB	_	_	10	AMOD	_	_
10	present	_	JJ	_	_	8	VMOD	_	_
11	in	_	IN	_	_	10	AMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	nuclei	_	NNS	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	primary	_	JJ	_	_	16	NMOD	_	_
16	monocytes	_	NNS	_	_	14	PMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	monocytic	_	JJ	_	_	20	NMOD	_	_
19	cell	_	NN	_	_	20	NMOD	_	_
20	lines	_	NNS	_	_	17	CONJ	_	_
21	in	_	IN	_	_	10	AMOD	_	_
22	the	_	DT	_	_	23	NMOD	_	_
23	absence	_	NN	_	_	21	PMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	exogenous	_	JJ	_	_	26	NMOD	_	_
26	stimuli	_	NNS	_	_	24	PMOD	_	_
27	as	_	IN	_	_	8	VMOD	_	_
28	demonstrated	_	VBN	_	_	27	SUB	_	_
29	by	_	IN	_	_	28	VMOD	_	_
30	mobility	_	NN	_	_	32	NMOD	_	_
31	shift	_	NN	_	_	32	NMOD	_	_
32	analysis	_	NN	_	_	29	PMOD	_	_
33	[	_	(	_	_	34	P	_	_
34	13	_	CD	_	_	28	PRN	_	_
35	]	_	)	_	_	34	P	_	_
36	.	_	.	_	_	8	P	_	_
		
1	Similarly	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	constitutively	_	RB	_	_	4	AMOD	_	_
4	active	_	JJ	_	_	5	NMOD	_	_
5	NF-kappaB	_	NN	_	_	6	VMOD	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	observed	_	VBN	_	_	6	VC	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	human	_	JJ	_	_	11	NMOD	_	_
10	alveolar	_	JJ	_	_	11	NMOD	_	_
11	macrophages	_	NNS	_	_	8	PMOD	_	_
12	[	_	(	_	_	13	P	_	_
13	14	_	CD	_	_	6	PRN	_	_
14	]	_	)	_	_	13	P	_	_
15	.	_	.	_	_	6	P	_	_
		
1	In	_	IN	_	_	10	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	classic/canonical	_	JJ	_	_	4	NMOD	_	_
4	pathway	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	10	P	_	_
6	the	_	DT	_	_	9	NMOD	_	_
7	NF-kappaB	_	NN	_	_	9	NMOD	_	_
8	p50/p65	_	NN	_	_	9	NMOD	_	_
9	complex	_	NN	_	_	10	VMOD	_	_
10	is	_	VBZ	_	_	0	ROOT	_	_
11	sequestered	_	VBN	_	_	10	VC	_	_
12	in	_	IN	_	_	11	VMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	cytosol	_	NN	_	_	12	PMOD	_	_
15	by	_	IN	_	_	11	VMOD	_	_
16	IkappaBalpha	_	NN	_	_	15	PMOD	_	_
17	[	_	(	_	_	18	P	_	_
18	15	_	CD	_	_	16	PRN	_	_
19	]	_	)	_	_	18	P	_	_
20	.	_	.	_	_	10	P	_	_
		
1	Upon	_	IN	_	_	10	VMOD	_	_
2	stimulation	_	NN	_	_	1	PMOD	_	_
3	by	_	IN	_	_	2	NMOD	_	_
4	cytokines	_	NNS	_	_	3	PMOD	_	_
5	or	_	CC	_	_	4	COORD	_	_
6	UV	_	NN	_	_	7	NMOD	_	_
7	radiation	_	NN	_	_	5	CONJ	_	_
8	,	_	,	_	_	10	P	_	_
9	IkappaBalpha	_	NN	_	_	10	VMOD	_	_
10	is	_	VBZ	_	_	0	ROOT	_	_
11	phosphorylated	_	VBN	_	_	10	VC	_	_
12	,	_	,	_	_	11	P	_	_
13	ubiquitinated	_	VBN	_	_	11	COORD	_	_
14	,	_	,	_	_	13	P	_	_
15	and	_	CC	_	_	13	COORD	_	_
16	degraded	_	VBN	_	_	15	CONJ	_	_
17	,	_	,	_	_	10	P	_	_
18	releasing	_	VBG	_	_	10	VC	_	_
19	NF-kappaB	_	NN	_	_	20	NMOD	_	_
20	p50/p65	_	NN	_	_	18	VMOD	_	_
21	to	_	TO	_	_	18	VMOD	_	_
22	translocate	_	VB	_	_	21	IM	_	_
23	to	_	TO	_	_	22	VMOD	_	_
24	the	_	DT	_	_	25	NMOD	_	_
25	nucleus	_	NN	_	_	23	PMOD	_	_
26	and	_	CC	_	_	22	COORD	_	_
27	transactivate	_	VB	_	_	26	CONJ	_	_
28	target	_	NN	_	_	29	NMOD	_	_
29	genes	_	NNS	_	_	27	VMOD	_	_
30	.	_	.	_	_	10	P	_	_
		
1	After	_	IN	_	_	9	VMOD	_	_
2	its	_	PRP$	_	_	3	NMOD	_	_
3	release	_	NN	_	_	1	PMOD	_	_
4	from	_	IN	_	_	3	NMOD	_	_
5	IkappaBalpha	_	NN	_	_	4	PMOD	_	_
6	,	_	,	_	_	9	P	_	_
7	NF-kappaB	_	NN	_	_	8	NMOD	_	_
8	p65	_	NN	_	_	9	VMOD	_	_
9	can	_	MD	_	_	0	ROOT	_	_
10	undergo	_	VB	_	_	9	VC	_	_
11	post-translational	_	JJ	_	_	12	NMOD	_	_
12	modification	_	NN	_	_	10	VMOD	_	_
13	to	_	TO	_	_	9	VMOD	_	_
14	activate	_	VB	_	_	13	IM	_	_
15	gene	_	NN	_	_	16	NMOD	_	_
16	transcription	_	NN	_	_	14	VMOD	_	_
17	.	_	.	_	_	9	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	role	_	NN	_	_	11	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	NF-kappaB	_	NN	_	_	6	NMOD	_	_
5	p65	_	NN	_	_	6	NMOD	_	_
6	phosphorylation	_	NN	_	_	3	PMOD	_	_
7	on	_	IN	_	_	2	NMOD	_	_
8	NF-kappaB	_	NN	_	_	10	NMOD	_	_
9	transcriptional	_	JJ	_	_	10	NMOD	_	_
10	activity	_	NN	_	_	7	PMOD	_	_
11	varies	_	VBZ	_	_	0	ROOT	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	stimulus	_	NN	_	_	12	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	time	_	NN	_	_	13	COORD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	stimulation	_	NN	_	_	16	PMOD	_	_
18	and	_	CC	_	_	15	COORD	_	_
19	cell	_	NN	_	_	20	NMOD	_	_
20	type	_	NN	_	_	18	CONJ	_	_
21	[	_	(	_	_	20	P	_	_
22	16	_	CD	_	_	20	COORD	_	_
23	]	_	)	_	_	13	P	_	_
24	.	_	.	_	_	11	P	_	_
		
1	Previous	_	JJ	_	_	2	NMOD	_	_
2	research	_	NN	_	_	3	VMOD	_	_
3	shows	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	phosphorylation	_	NN	_	_	15	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	NF-kappaB	_	NN	_	_	8	NMOD	_	_
8	p65	_	NN	_	_	6	PMOD	_	_
9	at	_	IN	_	_	5	NMOD	_	_
10	Ser276	_	NN	_	_	9	PMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	Ser529	_	NN	_	_	10	COORD	_	_
13	or	_	CC	_	_	12	COORD	_	_
14	Ser536	_	NN	_	_	13	CONJ	_	_
15	plays	_	VBZ	_	_	4	SUB	_	_
16	an	_	DT	_	_	18	NMOD	_	_
17	important	_	JJ	_	_	18	NMOD	_	_
18	role	_	NN	_	_	15	VMOD	_	_
19	in	_	IN	_	_	15	VMOD	_	_
20	regulating	_	VBG	_	_	19	PMOD	_	_
21	transcriptional	_	JJ	_	_	22	NMOD	_	_
22	activity	_	NN	_	_	20	VMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	NF-kappaB	_	NN	_	_	23	PMOD	_	_
25	[	_	(	_	_	24	P	_	_
26	17	_	CD	_	_	24	NMOD	_	_
27	]	_	)	_	_	24	P	_	_
28	.	_	.	_	_	3	P	_	_
		
1	In	_	IN	_	_	10	VMOD	_	_
2	TNFalpha-treated	_	JJ	_	_	4	NMOD	_	_
3	murine	_	JJ	_	_	4	NMOD	_	_
4	fibroblasts	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	10	P	_	_
6	Ser276	_	NN	_	_	10	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	NF-kappaB	_	NN	_	_	9	NMOD	_	_
9	p65	_	NN	_	_	7	PMOD	_	_
10	is	_	VBZ	_	_	0	ROOT	_	_
11	phosphorylated	_	VBN	_	_	10	VC	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	MSK1	_	NN	_	_	12	PMOD	_	_
14	to	_	TO	_	_	10	VC	_	_
15	enhance	_	VB	_	_	14	IM	_	_
16	NF-kappaB	_	NN	_	_	18	NMOD	_	_
17	transcriptional	_	JJ	_	_	18	NMOD	_	_
18	activity	_	NN	_	_	15	VMOD	_	_
19	[	_	(	_	_	20	P	_	_
20	18	_	CD	_	_	15	PRN	_	_
21	]	_	)	_	_	20	P	_	_
22	.	_	.	_	_	10	P	_	_
		
1	In	_	IN	_	_	10	VMOD	_	_
2	macrophages	_	NNS	_	_	1	PMOD	_	_
3	treated	_	VBN	_	_	2	APPO	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	endotoxin	_	NN	_	_	4	PMOD	_	_
6	,	_	,	_	_	10	P	_	_
7	NF-kappaB	_	NN	_	_	9	NMOD	_	_
8	transcription	_	NN	_	_	9	NMOD	_	_
9	activity	_	NN	_	_	10	VMOD	_	_
10	is	_	VBZ	_	_	0	ROOT	_	_
11	associated	_	VBN	_	_	10	VC	_	_
12	with	_	IN	_	_	11	VMOD	_	_
13	phosphorylation	_	NN	_	_	12	PMOD	_	_
14	on	_	IN	_	_	13	NMOD	_	_
15	Ser276	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	Ser536	_	NN	_	_	16	CONJ	_	_
18	that	_	WDT	_	_	19	VMOD	_	_
19	is	_	VBZ	_	_	13	NMOD	_	_
20	regulated	_	VBN	_	_	19	VC	_	_
21	through	_	IN	_	_	20	VMOD	_	_
22	protein	_	NN	_	_	24	NMOD	_	_
23	kinase	_	NN	_	_	24	NMOD	_	_
24	A	_	NN	_	_	21	PMOD	_	_
25	(	_	(	_	_	26	P	_	_
26	PKA	_	NN	_	_	24	PRN	_	_
27	)	_	)	_	_	26	P	_	_
28	and	_	CC	_	_	24	COORD	_	_
29	IKKbeta	_	NN	_	_	28	CONJ	_	_
30	respectively[16]	_	CD	_	_	29	NMOD	_	_
31	,	_	,	_	_	13	P	_	_
32	[	_	(	_	_	33	P	_	_
33	19	_	CD	_	_	11	PRN	_	_
34	]	_	)	_	_	33	P	_	_
35	.	_	.	_	_	10	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	human	_	JJ	_	_	4	NMOD	_	_
3	T	_	NN	_	_	4	NMOD	_	_
4	cells	_	NNS	_	_	1	PMOD	_	_
5	,	_	,	_	_	8	P	_	_
6	NF-kappaB	_	NN	_	_	7	NMOD	_	_
7	p65	_	NN	_	_	8	VMOD	_	_
8	is	_	VBZ	_	_	0	ROOT	_	_
9	constitutively	_	RB	_	_	8	VMOD	_	_
10	phosphorylated	_	VBN	_	_	8	VC	_	_
11	on	_	IN	_	_	10	VMOD	_	_
12	Ser536	_	NN	_	_	11	PMOD	_	_
13	to	_	TO	_	_	12	APPO	_	_
14	facilitate	_	VB	_	_	13	IM	_	_
15	NF-kappaB	_	NN	_	_	18	NMOD	_	_
16	p65	_	NN	_	_	18	NMOD	_	_
17	nuclear	_	JJ	_	_	18	NMOD	_	_
18	translocation	_	NN	_	_	14	VMOD	_	_
19	following	_	VBG	_	_	10	VMOD	_	_
20	cellular	_	JJ	_	_	21	NMOD	_	_
21	stimulation	_	NN	_	_	19	PMOD	_	_
22	[	_	(	_	_	21	P	_	_
23	20	_	CD	_	_	21	NMOD	_	_
24	]	_	)	_	_	21	P	_	_
25	.	_	.	_	_	8	P	_	_
		
1	Accumulating	_	VBG	_	_	2	NMOD	_	_
2	evidence	_	NN	_	_	3	VMOD	_	_
3	reveals	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	NF-kappaB	_	NN	_	_	7	NMOD	_	_
6	p65	_	NN	_	_	7	NMOD	_	_
7	phosphorylation	_	NN	_	_	10	VMOD	_	_
8	at	_	IN	_	_	7	NMOD	_	_
9	Ser276	_	NN	_	_	8	PMOD	_	_
10	is	_	VBZ	_	_	4	SUB	_	_
11	crucial	_	JJ	_	_	10	VMOD	_	_
12	for	_	IN	_	_	11	AMOD	_	_
13	its	_	PRP$	_	_	15	NMOD	_	_
14	transcriptional	_	JJ	_	_	15	NMOD	_	_
15	activity	_	NN	_	_	12	PMOD	_	_
16	.	_	.	_	_	3	P	_	_
		
1	Upon	_	IN	_	_	13	VMOD	_	_
2	nuclear	_	JJ	_	_	3	NMOD	_	_
3	translocation	_	NN	_	_	1	PMOD	_	_
4	,	_	,	_	_	13	P	_	_
5	phosphorylation	_	NN	_	_	13	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	Ser276	_	NN	_	_	6	PMOD	_	_
8	on	_	IN	_	_	5	NMOD	_	_
9	NF-kappaB	_	NN	_	_	10	NMOD	_	_
10	p65	_	NN	_	_	8	PMOD	_	_
11	by	_	IN	_	_	5	NMOD	_	_
12	PKA	_	NN	_	_	11	PMOD	_	_
13	recruits	_	VBZ	_	_	0	ROOT	_	_
14	the	_	DT	_	_	18	NMOD	_	_
15	transcription	_	NN	_	_	18	NMOD	_	_
16	co-activator	_	NN	_	_	18	NMOD	_	_
17	,	_	,	_	_	18	P	_	_
18	p300	_	NN	_	_	13	VMOD	_	_
19	to	_	TO	_	_	13	VMOD	_	_
20	potentiate	_	VB	_	_	19	IM	_	_
21	NF-kappaB-regulated	_	JJ	_	_	23	NMOD	_	_
22	gene	_	NN	_	_	23	NMOD	_	_
23	transcription	_	NN	_	_	20	VMOD	_	_
24	[	_	(	_	_	23	P	_	_
25	21	_	CD	_	_	23	NMOD	_	_
26	]	_	)	_	_	23	P	_	_
27	.	_	.	_	_	13	P	_	_
		
1	However	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	other	_	JJ	_	_	4	NMOD	_	_
4	studies	_	NNS	_	_	5	VMOD	_	_
5	show	_	VBP	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	PKA	_	NN	_	_	8	VMOD	_	_
8	inhibits	_	VBZ	_	_	6	SUB	_	_
9	NF-kappaB-regulated	_	JJ	_	_	11	NMOD	_	_
10	gene	_	NN	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	8	VMOD	_	_
12	by	_	IN	_	_	8	VMOD	_	_
13	stabilizing	_	VBG	_	_	12	PMOD	_	_
14	IkappaBalpha	_	NN	_	_	13	VMOD	_	_
15	[	_	(	_	_	14	P	_	_
16	22	_	CD	_	_	14	NMOD	_	_
17	]	_	)	_	_	14	P	_	_
18	,	_	,	_	_	14	P	_	_
19	[	_	(	_	_	20	P	_	_
20	23	_	CD	_	_	14	APPO	_	_
21	]	_	)	_	_	20	P	_	_
22	.	_	.	_	_	5	P	_	_
		
1	Interestingly	_	RB	_	_	8	VMOD	_	_
2	,	_	,	_	_	8	P	_	_
3	the	_	DT	_	_	6	NMOD	_	_
4	serine/threonine	_	NN	_	_	6	NMOD	_	_
5	kinase	_	NN	_	_	6	NMOD	_	_
6	Pim-1	_	NN	_	_	8	VMOD	_	_
7	directly	_	RB	_	_	8	VMOD	_	_
8	phosphorylates	_	VBZ	_	_	0	ROOT	_	_
9	NF-kappaB	_	NN	_	_	10	NMOD	_	_
10	p65	_	NN	_	_	8	VMOD	_	_
11	at	_	IN	_	_	8	VMOD	_	_
12	Ser276	_	NN	_	_	11	PMOD	_	_
13	by	_	IN	_	_	8	VMOD	_	_
14	stabilizing	_	VBG	_	_	13	PMOD	_	_
15	to	_	TO	_	_	14	VMOD	_	_
16	prevent	_	VB	_	_	15	IM	_	_
17	ubiquitin-proteasome	_	JJ	_	_	18	NMOD	_	_
18	degradation	_	NN	_	_	16	VMOD	_	_
19	[	_	(	_	_	18	P	_	_
20	24	_	CD	_	_	18	NMOD	_	_
21	]	_	)	_	_	18	P	_	_
22	.	_	.	_	_	8	P	_	_
		
1	Several	_	JJ	_	_	4	NMOD	_	_
2	other	_	JJ	_	_	4	NMOD	_	_
3	phosphorylation	_	NN	_	_	4	NMOD	_	_
4	sites	_	NNS	_	_	5	VMOD	_	_
5	are	_	VBP	_	_	0	ROOT	_	_
6	also	_	RB	_	_	5	VMOD	_	_
7	described	_	VBN	_	_	5	VC	_	_
8	to	_	TO	_	_	7	VMOD	_	_
9	enhance	_	VB	_	_	8	IM	_	_
10	NF-kappaB	_	NN	_	_	12	NMOD	_	_
11	gene	_	NN	_	_	12	NMOD	_	_
12	transactivation	_	NN	_	_	9	VMOD	_	_
13	[	_	(	_	_	14	P	_	_
14	25	_	CD	_	_	9	PRN	_	_
15	]	_	)	_	_	14	P	_	_
16	.	_	.	_	_	5	P	_	_
		
1	Here	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	investigate	_	VBP	_	_	0	ROOT	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	role	_	NN	_	_	4	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	protein	_	NN	_	_	10	NMOD	_	_
9	kinase	_	NN	_	_	10	NMOD	_	_
10	C	_	NN	_	_	7	PMOD	_	_
11	(	_	(	_	_	12	P	_	_
12	PKC	_	NN	_	_	10	PRN	_	_
13	)	_	)	_	_	12	P	_	_
14	in	_	IN	_	_	6	NMOD	_	_
15	M-CSF-stimulated	_	JJ	_	_	17	NMOD	_	_
16	NF-kappaB	_	NN	_	_	17	NMOD	_	_
17	activation	_	NN	_	_	14	PMOD	_	_
18	.	_	.	_	_	4	P	_	_
		
1	PKC	_	NN	_	_	2	NMOD	_	_
2	proteins	_	NNS	_	_	3	VMOD	_	_
3	are	_	VBP	_	_	0	ROOT	_	_
4	multifunctional	_	JJ	_	_	5	NMOD	_	_
5	kinases	_	NNS	_	_	3	VMOD	_	_
6	that	_	WDT	_	_	7	VMOD	_	_
7	differ	_	VBP	_	_	5	NMOD	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	structure	_	NN	_	_	8	PMOD	_	_
10	,	_	,	_	_	9	P	_	_
11	function	_	NN	_	_	9	COORD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	co-factor	_	NN	_	_	14	NMOD	_	_
14	requirement	_	NN	_	_	12	CONJ	_	_
15	[	_	(	_	_	14	P	_	_
16	26	_	CD	_	_	14	COORD	_	_
17	]	_	)	_	_	9	P	_	_
18	.	_	.	_	_	3	P	_	_
		
1	PKCs	_	NNS	_	_	2	VMOD	_	_
2	are	_	VBP	_	_	0	ROOT	_	_
3	involved	_	VBN	_	_	2	VC	_	_
4	in	_	IN	_	_	3	VMOD	_	_
5	diverse	_	JJ	_	_	7	NMOD	_	_
6	cell	_	NN	_	_	7	NMOD	_	_
7	responses	_	NNS	_	_	4	PMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	including	_	VBG	_	_	7	NMOD	_	_
10	cell	_	NN	_	_	11	NMOD	_	_
11	growth	_	NN	_	_	9	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	survival	_	NN	_	_	11	COORD	_	_
14	,	_	,	_	_	13	P	_	_
15	differentiation	_	NN	_	_	13	COORD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	development	_	NN	_	_	16	CONJ	_	_
18	[	_	(	_	_	17	P	_	_
19	27	_	CD	_	_	17	NMOD	_	_
20	]	_	)	_	_	17	P	_	_
21	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	5	NMOD	_	_
2	12	_	CD	_	_	5	NMOD	_	_
3	closely	_	RB	_	_	4	AMOD	_	_
4	related	_	JJ	_	_	5	NMOD	_	_
5	enzymes	_	NNS	_	_	10	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	PKC	_	NN	_	_	9	NMOD	_	_
9	family	_	NN	_	_	6	PMOD	_	_
10	are	_	VBP	_	_	0	ROOT	_	_
11	divided	_	VBN	_	_	10	VC	_	_
12	into	_	IN	_	_	11	VMOD	_	_
13	three	_	CD	_	_	14	NMOD	_	_
14	classes	_	NNS	_	_	12	PMOD	_	_
15	:	_	:	_	_	14	P	_	_
16	conventional	_	JJ	_	_	14	APPO	_	_
17	(	_	(	_	_	18	P	_	_
18	cPKCs	_	NN	_	_	16	AMOD	_	_
19	:	_	:	_	_	18	P	_	_
20	alpha	_	NN	_	_	22	NMOD	_	_
21	betaI	_	NN	_	_	22	NMOD	_	_
22	betaII	_	NN	_	_	25	VMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	gamma	_	NN	_	_	23	CONJ	_	_
25	require	_	VBP	_	_	18	COORD	_	_
26	Ca2+	_	NN	_	_	25	VMOD	_	_
27	and	_	CC	_	_	26	COORD	_	_
28	diacylglycerol	_	NN	_	_	27	CONJ	_	_
29	(	_	(	_	_	30	P	_	_
30	DAG	_	NN	_	_	28	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	;	_	:	_	_	25	P	_	_
33	novel	_	JJ	_	_	47	VMOD	_	_
34	(	_	(	_	_	35	P	_	_
35	nPKCs	_	NNS	_	_	33	PRN	_	_
36	:	_	:	_	_	35	P	_	_
37	delta	_	NN	_	_	35	APPO	_	_
38	,	_	,	_	_	37	P	_	_
39	epsilon	_	NN	_	_	37	COORD	_	_
40	,	_	,	_	_	39	P	_	_
41	eta	_	NN	_	_	39	COORD	_	_
42	,	_	,	_	_	41	P	_	_
43	theta	_	NN	_	_	41	COORD	_	_
44	and	_	CC	_	_	43	COORD	_	_
45	mu	_	NN	_	_	44	CONJ	_	_
46	)	_	)	_	_	35	P	_	_
47	require	_	VBP	_	_	25	COORD	_	_
48	DAG	_	NN	_	_	47	VMOD	_	_
49	;	_	:	_	_	47	P	_	_
50	and	_	CC	_	_	47	COORD	_	_
51	atypical	_	JJ	_	_	61	VMOD	_	_
52	(	_	(	_	_	53	P	_	_
53	aPKCs	_	NN	_	_	51	PRN	_	_
54	:	_	:	_	_	53	P	_	_
55	xi	_	NN	_	_	53	COORD	_	_
56	,	_	,	_	_	55	P	_	_
57	iota	_	NN	_	_	55	COORD	_	_
58	and	_	CC	_	_	57	COORD	_	_
59	lambda	_	NN	_	_	58	CONJ	_	_
60	)	_	)	_	_	53	P	_	_
61	require	_	VBP	_	_	50	CONJ	_	_
62	neither	_	CC	_	_	63	DEP	_	_
63	Ca2+	_	NN	_	_	61	VMOD	_	_
64	nor	_	CC	_	_	63	COORD	_	_
65	DAG	_	NN	_	_	64	CONJ	_	_
66	.	_	.	_	_	10	P	_	_
		
1	Monocytes	_	NNS	_	_	5	VMOD	_	_
2	and	_	CC	_	_	1	COORD	_	_
3	macrophages	_	NNS	_	_	2	CONJ	_	_
4	predominantly	_	RB	_	_	5	VMOD	_	_
5	express	_	VBP	_	_	0	ROOT	_	_
6	conventional	_	JJ	_	_	8	NMOD	_	_
7	PKC	_	NN	_	_	8	NMOD	_	_
8	isoforms	_	NNS	_	_	5	VMOD	_	_
9	(	_	(	_	_	11	P	_	_
10	PKCalpha	_	NN	_	_	11	NMOD	_	_
11	PKCbetaI	_	NN	_	_	8	PRN	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	PKCbetaII	_	NN	_	_	12	CONJ	_	_
14	)	_	)	_	_	11	P	_	_
15	and	_	CC	_	_	8	COORD	_	_
16	novel	_	JJ	_	_	17	NMOD	_	_
17	PKCs	_	NNS	_	_	15	CONJ	_	_
18	(	_	(	_	_	19	P	_	_
19	PKCdelta	_	NN	_	_	17	PRN	_	_
20	and	_	CC	_	_	19	COORD	_	_
21	PKCepsilon	_	NN	_	_	20	CONJ	_	_
22	)	_	)	_	_	19	P	_	_
23	.	_	.	_	_	5	P	_	_
		
1	Conventional	_	JJ	_	_	2	NMOD	_	_
2	PKCs	_	NNS	_	_	3	VMOD	_	_
3	regulate	_	VBP	_	_	0	ROOT	_	_
4	differentiation	_	NN	_	_	3	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	11	NMOD	_	_
7	human	_	JJ	_	_	11	NMOD	_	_
8	promyelocytic	_	JJ	_	_	11	NMOD	_	_
9	leukemia	_	NN	_	_	11	NMOD	_	_
10	cell	_	NN	_	_	11	NMOD	_	_
11	line	_	NN	_	_	5	PMOD	_	_
12	HL60	_	NN	_	_	11	APPO	_	_
13	to	_	TO	_	_	4	NMOD	_	_
14	macrophages	_	NNS	_	_	13	PMOD	_	_
15	[	_	(	_	_	16	P	_	_
16	28	_	CD	_	_	3	PRN	_	_
17	]	_	)	_	_	16	P	_	_
18	.	_	.	_	_	3	P	_	_
		
1	PKCalpha	_	NN	_	_	2	VMOD	_	_
2	induces	_	VBZ	_	_	0	ROOT	_	_
3	IL-1alpha	_	NN	_	_	2	VMOD	_	_
4	,	_	,	_	_	3	P	_	_
5	iNOS	_	NN	_	_	3	COORD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	TNFalpha	_	NN	_	_	9	NMOD	_	_
8	mRNA	_	NN	_	_	9	NMOD	_	_
9	production	_	NN	_	_	6	CONJ	_	_
10	after	_	IN	_	_	9	NMOD	_	_
11	lipopolysaccharide	_	NN	_	_	15	NMOD	_	_
12	(	_	(	_	_	13	P	_	_
13	LPS	_	NN	_	_	11	PRN	_	_
14	)	_	)	_	_	13	P	_	_
15	exposure	_	NN	_	_	10	PMOD	_	_
16	[	_	(	_	_	9	P	_	_
17	29	_	CD	_	_	9	COORD	_	_
18	]	_	)	_	_	3	P	_	_
19	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	6	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	accumulating	_	VBG	_	_	5	NMOD	_	_
5	evidence	_	NN	_	_	6	VMOD	_	_
6	suggests	_	VBZ	_	_	0	ROOT	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	conventional	_	JJ	_	_	9	NMOD	_	_
9	PKCs	_	NNS	_	_	12	VMOD	_	_
10	like	_	IN	_	_	9	NMOD	_	_
11	PKCalpha	_	NN	_	_	10	PMOD	_	_
12	have	_	VBP	_	_	7	SUB	_	_
13	anti-apoptotic	_	JJ	_	_	14	NMOD	_	_
14	functions	_	NNS	_	_	12	VMOD	_	_
15	.	_	.	_	_	6	P	_	_
		
1	For	_	IN	_	_	5	VMOD	_	_
2	example	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	PKCalpha	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	overexpressed	_	VBN	_	_	5	VC	_	_
7	in	_	IN	_	_	6	VMOD	_	_
8	a	_	DT	_	_	9	NMOD	_	_
9	variety	_	NN	_	_	7	PMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	tumor	_	NN	_	_	12	NMOD	_	_
12	cells	_	NNS	_	_	10	PMOD	_	_
13	including	_	VBG	_	_	12	NMOD	_	_
14	gliomas	_	NNS	_	_	13	PMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	liver	_	NN	_	_	14	APPO	_	_
17	,	_	,	_	_	16	P	_	_
18	and	_	CC	_	_	16	COORD	_	_
19	lung	_	NN	_	_	18	CONJ	_	_
20	[	_	(	_	_	19	P	_	_
21	30	_	CD	_	_	19	NMOD	_	_
22	]	_	)	_	_	19	P	_	_
23	,	_	,	_	_	14	P	_	_
24	[	_	(	_	_	25	P	_	_
25	31	_	CD	_	_	6	PRN	_	_
26	]	_	)	_	_	25	P	_	_
27	.	_	.	_	_	5	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	epithelial	_	JJ	_	_	3	NMOD	_	_
3	cells	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	8	P	_	_
5	inhibition	_	NN	_	_	8	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	PKCalpha	_	NN	_	_	6	PMOD	_	_
8	induces	_	VBZ	_	_	0	ROOT	_	_
9	PKCdelta-dependent	_	JJ	_	_	10	NMOD	_	_
10	apoptosis	_	NN	_	_	8	VMOD	_	_
11	[	_	(	_	_	12	P	_	_
12	31	_	CD	_	_	8	PRN	_	_
13	]	_	)	_	_	12	P	_	_
14	.	_	.	_	_	8	P	_	_
		
1	Interestingly	_	RB	_	_	27	VMOD	_	_
2	,	_	,	_	_	27	P	_	_
3	in	_	IN	_	_	27	VMOD	_	_
4	human	_	JJ	_	_	5	NMOD	_	_
5	monocytes	_	NNS	_	_	3	PMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	premonocytic	_	JJ	_	_	10	NMOD	_	_
8	THP-1	_	NN	_	_	10	NMOD	_	_
9	leukemia	_	NN	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	6	CONJ	_	_
11	,	_	,	_	_	5	P	_	_
12	novel	_	JJ	_	_	13	NMOD	_	_
13	PKCs	_	NNS	_	_	16	VMOD	_	_
14	like	_	IN	_	_	13	NMOD	_	_
15	PKCdelta	_	NN	_	_	14	PMOD	_	_
16	have	_	VBP	_	_	5	NMOD	_	_
17	the	_	DT	_	_	19	NMOD	_	_
18	opposite	_	JJ	_	_	19	NMOD	_	_
19	effect	_	NN	_	_	16	VMOD	_	_
20	on	_	IN	_	_	16	VMOD	_	_
21	cell	_	NN	_	_	22	NMOD	_	_
22	survival	_	NN	_	_	20	PMOD	_	_
23	,	_	,	_	_	27	P	_	_
24	Voss	_	NNP	_	_	27	VMOD	_	_
25	et	_	FW	_	_	24	NMOD	_	_
26	al	_	FW	_	_	24	NMOD	_	_
27	showed	_	VBD	_	_	0	ROOT	_	_
28	that	_	IN	_	_	27	VMOD	_	_
29	PKCdelta	_	NN	_	_	31	VMOD	_	_
30	directly	_	RB	_	_	31	VMOD	_	_
31	phosphorylates	_	VBZ	_	_	28	SUB	_	_
32	caspase-3	_	NN	_	_	31	VMOD	_	_
33	and	_	CC	_	_	31	COORD	_	_
34	promotes	_	VBZ	_	_	33	CONJ	_	_
35	etoposide-induced	_	JJ	_	_	36	NMOD	_	_
36	apoptosis	_	NN	_	_	34	VMOD	_	_
37	[	_	(	_	_	38	P	_	_
38	32	_	CD	_	_	34	PRN	_	_
39	]	_	)	_	_	38	P	_	_
40	.	_	.	_	_	27	P	_	_
		
1	Moreover	_	RB	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	knockout	_	JJ	_	_	5	NMOD	_	_
4	mouse	_	NN	_	_	5	NMOD	_	_
5	studies	_	NNS	_	_	6	VMOD	_	_
6	suggest	_	VBP	_	_	0	ROOT	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	another	_	DT	_	_	10	NMOD	_	_
9	novel	_	JJ	_	_	10	NMOD	_	_
10	PKC	_	NN	_	_	13	VMOD	_	_
11	,	_	,	_	_	10	P	_	_
12	PKCepsilon	_	NN	_	_	10	APPO	_	_
13	is	_	VBZ	_	_	7	SUB	_	_
14	critically	_	RB	_	_	13	VMOD	_	_
15	involved	_	VBN	_	_	13	VC	_	_
16	in	_	IN	_	_	15	VMOD	_	_
17	early	_	JJ	_	_	19	NMOD	_	_
18	LPS-mediated	_	JJ	_	_	19	NMOD	_	_
19	signaling	_	NN	_	_	16	PMOD	_	_
20	in	_	IN	_	_	19	NMOD	_	_
21	activated	_	VBN	_	_	22	NMOD	_	_
22	macrophages	_	NNS	_	_	20	PMOD	_	_
23	[	_	(	_	_	24	P	_	_
24	33	_	CD	_	_	15	PRN	_	_
25	]	_	)	_	_	24	P	_	_
26	.	_	.	_	_	6	P	_	_
		
1	Previously	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	reported	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	M-CSF	_	NN	_	_	7	VMOD	_	_
7	promotes	_	VBZ	_	_	5	SUB	_	_
8	monocyte	_	NN	_	_	9	NMOD	_	_
9	survival	_	NN	_	_	7	VMOD	_	_
10	through	_	IN	_	_	7	VMOD	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	activation	_	NN	_	_	10	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	PI3-K/AKT	_	NN	_	_	16	NMOD	_	_
16	pathway	_	NN	_	_	13	PMOD	_	_
17	[	_	(	_	_	18	P	_	_
18	3	_	CD	_	_	7	PRN	_	_
19	]	_	)	_	_	18	P	_	_
20	.	_	.	_	_	4	P	_	_
		
1	In	_	IN	_	_	8	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	AKT	_	NN	_	_	5	NMOD	_	_
5	activation	_	NN	_	_	3	PMOD	_	_
6	,	_	,	_	_	8	P	_	_
7	M-CSF	_	NN	_	_	8	VMOD	_	_
8	stimulates	_	VBZ	_	_	0	ROOT	_	_
9	PKC	_	NN	_	_	8	VMOD	_	_
10	in	_	IN	_	_	9	NMOD	_	_
11	human	_	JJ	_	_	12	NMOD	_	_
12	monocytes	_	NNS	_	_	10	PMOD	_	_
13	and	_	CC	_	_	8	COORD	_	_
14	increases	_	VBZ	_	_	13	CONJ	_	_
15	NF-kappaB	_	NN	_	_	17	NMOD	_	_
16	DNA	_	NN	_	_	17	NMOD	_	_
17	binding	_	NN	_	_	14	VMOD	_	_
18	[	_	(	_	_	17	P	_	_
19	34	_	CD	_	_	17	NMOD	_	_
20	]	_	)	_	_	17	P	_	_
21	.	_	.	_	_	8	P	_	_
		
1	However	_	RB	_	_	17	VMOD	_	_
2	,	_	,	_	_	17	P	_	_
3	whether	_	IN	_	_	17	VMOD	_	_
4	PKC	_	NN	_	_	8	VMOD	_	_
5	and/or	_	CC	_	_	4	COORD	_	_
6	NF-kappaB	_	NN	_	_	7	NMOD	_	_
7	activation	_	NN	_	_	5	CONJ	_	_
8	is	_	VBZ	_	_	3	SUB	_	_
9	critical	_	JJ	_	_	8	VMOD	_	_
10	in	_	IN	_	_	9	AMOD	_	_
11	M-CSF-stimulated	_	JJ	_	_	14	NMOD	_	_
12	mononuclear	_	JJ	_	_	14	NMOD	_	_
13	phagocyte	_	NN	_	_	14	NMOD	_	_
14	survival	_	NN	_	_	10	PMOD	_	_
15	and/or	_	CC	_	_	14	COORD	_	_
16	differentiation	_	NN	_	_	15	CONJ	_	_
17	is	_	VBZ	_	_	0	ROOT	_	_
18	unclear	_	JJ	_	_	17	VMOD	_	_
19	.	_	.	_	_	17	P	_	_
		
1	In	_	IN	_	_	6	VMOD	_	_
2	other	_	JJ	_	_	3	NMOD	_	_
3	cells	_	NNS	_	_	1	PMOD	_	_
4	,	_	,	_	_	6	P	_	_
5	PKC	_	NN	_	_	6	VMOD	_	_
6	plays	_	VBZ	_	_	0	ROOT	_	_
7	an	_	DT	_	_	9	NMOD	_	_
8	important	_	JJ	_	_	9	NMOD	_	_
9	role	_	NN	_	_	6	VMOD	_	_
10	in	_	IN	_	_	6	VMOD	_	_
11	NF-kappaB	_	NN	_	_	12	NMOD	_	_
12	activation	_	NN	_	_	10	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	cell	_	NN	_	_	15	NMOD	_	_
15	survival	_	NN	_	_	13	CONJ	_	_
16	[	_	(	_	_	17	P	_	_
17	35	_	CD	_	_	15	PRN	_	_
18	]	_	)	_	_	17	P	_	_
19	,	_	,	_	_	6	P	_	_
20	however	_	WRB	_	_	34	VMOD	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	specific	_	JJ	_	_	23	NMOD	_	_
23	mechanisms	_	NNS	_	_	34	VMOD	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	this	_	DT	_	_	26	NMOD	_	_
26	activation	_	NN	_	_	24	PMOD	_	_
27	and	_	CC	_	_	23	COORD	_	_
28	the	_	DT	_	_	30	NMOD	_	_
29	biological	_	JJ	_	_	30	NMOD	_	_
30	effects	_	NNS	_	_	27	CONJ	_	_
31	on	_	IN	_	_	30	NMOD	_	_
32	cellular	_	JJ	_	_	33	NMOD	_	_
33	phenotype	_	NN	_	_	31	PMOD	_	_
34	are	_	VBP	_	_	6	VMOD	_	_
35	not	_	RB	_	_	34	VMOD	_	_
36	known	_	VBN	_	_	34	VC	_	_
37	.	_	.	_	_	6	P	_	_
		
1	Therefore	_	RB	_	_	4	VMOD	_	_
2	,	_	,	_	_	4	P	_	_
3	we	_	PRP	_	_	4	VMOD	_	_
4	focused	_	VBD	_	_	0	ROOT	_	_
5	at	_	IN	_	_	4	VMOD	_	_
6	understanding	_	VBG	_	_	5	PMOD	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	role	_	NN	_	_	6	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	PKC	_	NN	_	_	9	PMOD	_	_
11	in	_	IN	_	_	8	NMOD	_	_
12	the	_	DT	_	_	13	NMOD	_	_
13	regulation	_	NN	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	NF-kappaB	_	NN	_	_	16	NMOD	_	_
16	activation	_	NN	_	_	14	PMOD	_	_
17	and	_	CC	_	_	16	COORD	_	_
18	M-CSF-induced	_	JJ	_	_	20	NMOD	_	_
19	monocyte	_	NN	_	_	20	NMOD	_	_
20	survival	_	NN	_	_	17	CONJ	_	_
21	.	_	.	_	_	4	P	_	_
		
1	Here	_	RB	_	_	3	VMOD	_	_
2	we	_	PRP	_	_	3	VMOD	_	_
3	demonstrates	_	VBZ	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	M-CSF	_	NN	_	_	6	VMOD	_	_
6	upregulated	_	VBD	_	_	4	SUB	_	_
7	the	_	DT	_	_	9	NMOD	_	_
8	NF-kappaB	_	NN	_	_	9	NMOD	_	_
9	transcription	_	NN	_	_	6	VMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	cell	_	NN	_	_	12	NMOD	_	_
12	survival	_	NN	_	_	10	CONJ	_	_
13	in	_	IN	_	_	9	NMOD	_	_
14	human	_	JJ	_	_	13	PMOD	_	_
15	and	_	CC	_	_	14	COORD	_	_
16	mouse	_	NN	_	_	15	CONJ	_	_
17	macrophages	_	NNS	_	_	16	COORD	_	_
18	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	activity	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	reduced	_	VBN	_	_	3	VC	_	_
5	by	_	IN	_	_	4	VMOD	_	_
6	the	_	DT	_	_	14	NMOD	_	_
7	conventional	_	JJ	_	_	14	NMOD	_	_
8	,	_	,	_	_	7	P	_	_
9	but	_	CC	_	_	7	COORD	_	_
10	not	_	RB	_	_	9	COORD	_	_
11	novel	_	JJ	_	_	9	CONJ	_	_
12	,	_	,	_	_	7	P	_	_
13	PKC	_	NN	_	_	14	NMOD	_	_
14	inhibitors	_	NNS	_	_	5	PMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	dominant	_	JJ	_	_	19	NMOD	_	_
17	negative	_	JJ	_	_	19	NMOD	_	_
18	PKCalpha	_	NN	_	_	19	NMOD	_	_
19	constructs	_	NNS	_	_	14	COORD	_	_
20	or	_	CC	_	_	19	COORD	_	_
21	PKCalpha	_	NN	_	_	22	NMOD	_	_
22	siRNA	_	NN	_	_	20	CONJ	_	_
23	.	_	.	_	_	3	P	_	_
		
1	Conventional	_	JJ	_	_	2	NMOD	_	_
2	PKC	_	NN	_	_	3	VMOD	_	_
3	regulated	_	VBD	_	_	0	ROOT	_	_
4	NF-kappaB-regulated	_	JJ	_	_	6	NMOD	_	_
5	gene	_	NN	_	_	6	NMOD	_	_
6	expression	_	NN	_	_	3	VMOD	_	_
7	and	_	CC	_	_	3	COORD	_	_
8	phosphorylation	_	NN	_	_	14	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	Ser276	_	NN	_	_	9	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	NF-kappaB	_	NN	_	_	13	NMOD	_	_
13	p65	_	NN	_	_	11	PMOD	_	_
14	occurred	_	VBD	_	_	7	CONJ	_	_
15	in	_	IN	_	_	14	VMOD	_	_
16	an	_	DT	_	_	18	NMOD	_	_
17	M-CSF-dependent	_	JJ	_	_	18	NMOD	_	_
18	fashion	_	NN	_	_	15	PMOD	_	_
19	correlating	_	VBG	_	_	18	APPO	_	_
20	with	_	IN	_	_	19	VMOD	_	_
21	its	_	PRP$	_	_	24	NMOD	_	_
22	maximal	_	JJ	_	_	24	NMOD	_	_
23	transcriptional	_	JJ	_	_	24	NMOD	_	_
24	activity	_	NN	_	_	20	PMOD	_	_
25	.	_	.	_	_	3	P	_	_
		
1	Furthermore	_	RB	_	_	10	VMOD	_	_
2	,	_	,	_	_	10	P	_	_
3	PKCalpha-regulated	_	JJ	_	_	4	NMOD	_	_
4	phosphorylation	_	NN	_	_	10	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	Ser276	_	NN	_	_	5	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	NF-kappaB	_	NN	_	_	9	NMOD	_	_
9	p65	_	NN	_	_	7	PMOD	_	_
10	plays	_	VBZ	_	_	0	ROOT	_	_
11	an	_	DT	_	_	13	NMOD	_	_
12	important	_	JJ	_	_	13	NMOD	_	_
13	role	_	NN	_	_	10	VMOD	_	_
14	in	_	IN	_	_	10	VMOD	_	_
15	regulating	_	VBG	_	_	14	PMOD	_	_
16	its	_	PRP$	_	_	17	NMOD	_	_
17	activity	_	NN	_	_	15	VMOD	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	mononuclear	_	JJ	_	_	20	NMOD	_	_
20	phagocytes	_	NNS	_	_	18	PMOD	_	_
21	and	_	CC	_	_	20	COORD	_	_
22	murine	_	JJ	_	_	24	NMOD	_	_
23	embryonic	_	JJ	_	_	24	NMOD	_	_
24	fibroblasts	_	NNS	_	_	21	CONJ	_	_
25	.	_	.	_	_	10	P	_	_
		
